Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14).
Haematologica
; 107(1): 321-325, 2022 01 01.
Article
in En
| MEDLINE
| ID: mdl-34587718
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2022
Document type:
Article